SCHOEMAKER KATHLEEN K

CIK 000120778931 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001207789

Recent Transactions

50 trades

Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−50,743→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−78,369→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−27,500→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−2,972,678→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−7,313,241→ 0 total
Conversion
Achaogen, Inc.
Common Stock
2014-03-17+1,987,049→ 1,987,049 total
Conversion
Achaogen, Inc.
Series B Preferred Stock
2014-03-17−625,065→ 0 total
Conversion
Achaogen, Inc.
Series D Preferred Stock
2014-03-17−435,663→ 0 total
Conversion
Achaogen, Inc.
Series B Preferred Stock
2014-03-17−10,661→ 0 total
Conversion
Achaogen, Inc.
Common Stock
2014-03-17+33,890→ 33,890 total
Conversion
Achaogen, Inc.
Series C Preferred Stock
2014-03-17−15,799→ 0 total
Conversion
Achaogen, Inc.
Series D Preferred Stock
2014-03-17−7,430→ 0 total
Conversion
Achaogen, Inc.
Series C Preferred Stock
2014-03-17−926,321→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Series C Preferred Stock
2014-02-04−9,469→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04−156→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2014-02-04+1,752,707→ 1,752,707 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04+21,041→ 21,041 total
Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2014-02-04+13,004→ 13,004 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04−21,041→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Series B Preferred Stock
2014-02-04−476,464→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Series B Preferred Stock
2014-02-04−3,535→ 0 total
Conversion
Dicerna Pharmaceuticals Inc
Warrant
2014-02-04+156→ 156 total
Conversion
Dicerna Pharmaceuticals Inc
Series C Preferred Stock
2014-02-04−1,276,243→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series B Preferred Stock
2013-11-19−6,071→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Common Stock
2013-11-19+54,390→ 54,390 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series D Preferred Stock
2013-11-19−2,283,114→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series B Preferred Stock
2013-11-19−356,111→ 0 total
Other
TANDEM DIABETES CARE INC$TNDM
Warrant to Purchase Common Stock
2013-11-19+6,008→ 6,008 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Common Stock
2013-11-19+3,189,058→ 3,189,058 total
Other
TANDEM DIABETES CARE INC$TNDM
Warrant to Purchase Series D Preferred Stock
2013-11-19−590,403→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series C Preferred Stock
2013-11-19−549,833→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series D Preferred Stock
2013-11-19−38,941→ 0 total
Other
TANDEM DIABETES CARE INC$TNDM
Warrant to Purchase Common Stock
2013-11-19+352,351→ 352,351 total
Other
TANDEM DIABETES CARE INC$TNDM
Warrant to Purchase Series D Preferred Stock
2013-11-19−10,068→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Series C Preferred Stock
2013-11-19−9,378→ 0 total
Conversion
VERACYTE, INC.$VCYT
Common Stock
2013-11-04+22,730→ 22,730 total
Conversion
VERACYTE, INC.$VCYT
Series C Preferred Stock
2013-11-04−680,972→ 0 total
Conversion
VERACYTE, INC.$VCYT
Series C Preferred Stock
2013-11-04−5,053→ 0 total
Conversion
VERACYTE, INC.$VCYT
Common Stock
2013-11-04+3,063,294→ 3,063,294 total
Conversion
VERACYTE, INC.$VCYT
Series B Preferred Stock
2013-11-04−2,382,322→ 0 total
Conversion
VERACYTE, INC.$VCYT
Series B Preferred Stock
2013-11-04−17,677→ 0 total
Conversion
Evoke Pharma Inc$EVOK
Series A Preferred Stock
2013-09-30−1,114,327→ 0 total
Conversion
Evoke Pharma Inc$EVOK
Series A Preferred Stock
2013-09-30−19,006→ 0 total
Conversion
Evoke Pharma Inc$EVOK
Common Stock
2013-09-30+1,114,327→ 1,114,327 total
Conversion
Evoke Pharma Inc$EVOK
Common Stock
2013-09-30+19,006→ 19,006 total
Conversion
Tobira Therapeutics, Inc.
Series D Preferred Stock
2013-08-27−7,407→ 0 total
Conversion
Tobira Therapeutics, Inc.
Series C Preferred Stock
2013-08-27−2,899→ 0 total
Conversion
Tobira Therapeutics, Inc.
Common Stock
2013-08-27+7,407→ 14,920 total
Conversion
Tobira Therapeutics, Inc.
Series E Preferred Stock
2013-08-27−225,913→ 0 total
Conversion
Tobira Therapeutics, Inc.
Common Stock
2013-08-27+394,969→ 430,516 total

Companies

Recent Filings

Address

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE

PRINCETON, NJ, 08542

View on SEC.gov